Lafutidine injecta and its prepn
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- ι»ζ―ε
- Publication Date
- 2003-06-04
- Estimated Expiration
- Not applicable Β· inactive patent
Abstract
Description
Technical field:
[0001] The invention relates to the field of preparation processing, in particular to a preparation containing lafutidine and a preparation method thereof. Background technique:
[0002] The chemical structure of lafutidine is:
[0003] Chemical name: (Β±)-2-(2-furanmethylsulfinyl)-N-{4-[4-(1-piperidylmethyl)-2-pyridyloxy]-cis-2-butene acetamide
[0004] Lafutidine (lafutidine) is a new generation of H 2 Receptor antagonist, mainly used in the treatment of peptic ulcer, this product can reduce the basal secretion of gastric acid, and inhibit the secretion of gastric acid stimulated by histamine, gastrin and urethane. Compared with other similar drugs (such as ranitidine and famotidine), this product is more effective for H 2 The blocking effect of the receptor is more effective and long-lasting, so it has the advantage of a more sustained anti-gastric acid secretion effect. Only lafutidine tablets are currently used clinically, for oral application. ...